Kolb Ryan, Sutterwala Fayyaz S, Zhang Weizhou
Department of Pathology, University of Iowa Carver College of Medicine, Iowa City, IA, USA.
Division of Infectious Diseases, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Curr Opin Pharmacol. 2016 Aug;29:77-89. doi: 10.1016/j.coph.2016.07.005. Epub 2016 Jul 16.
Obesity is a growing public health problem and affects 35% US adults. Obesity increases the risk of many cancer types and is associated with poor outcomes. Clinical management of cancer patients has been essentially the same between normal weight and obese individuals. Understanding causal mechanisms by which obesity drives cancer initiation and progression is essential for the development of novel precision therapy for obese cancer patients. One caveat is that various mechanisms have been proposed for different cancer types for their progression under obesity. Since obesity is known to have global impact on inflammation, here we will summarize recent literature and discuss the potential of inflammation being the common causal mechanism to promote cancer promotion across cancer types.
肥胖是一个日益严重的公共卫生问题,影响着35%的美国成年人。肥胖会增加多种癌症类型的风险,并与不良预后相关。在正常体重和肥胖个体之间,癌症患者的临床管理基本相同。了解肥胖驱动癌症发生和进展的因果机制对于开发针对肥胖癌症患者的新型精准疗法至关重要。一个需要注意的问题是,针对肥胖情况下不同癌症类型的进展,已经提出了各种机制。由于已知肥胖会对炎症产生全局性影响,因此我们将在此总结近期文献,并讨论炎症作为促进不同癌症类型癌症发展的共同因果机制的可能性。